 | • レポートコード：B-GIR08C2713 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ハーセプチンバイオシミラーの世界市場について調べ、まとめました。種類別セグメントは、乳癌、大腸癌、白血病、リンパ腫、その他等、用途別セグメントは、病院及び診療所、腫瘍センター、その他等に区分しました。ハーセプチンバイオシミラーの世界市場概観、企業動向、企業別ハーセプチンバイオシミラーシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ハーセプチンバイオシミラーの市場概観 ・ハーセプチンバイオシミラーの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ハーセプチンバイオシミラーの企業別販売動向、市場シェア、市場集中度、競争動向 ・ハーセプチンバイオシミラーの世界市場規模 ・ハーセプチンバイオシミラーの北米市場分析（アメリカ、カナダ、メキシコ等） ・ハーセプチンバイオシミラーのアメリカ市場規模推移 ・ハーセプチンバイオシミラーのカナダ市場規模推移 ・ハーセプチンバイオシミラーのメキシコ市場規模推移 ・ハーセプチンバイオシミラーのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ハーセプチンバイオシミラーのドイツ市場規模推移 ・ハーセプチンバイオシミラーのイギリス市場規模推移 ・ハーセプチンバイオシミラーのロシア市場規模推移 ・ハーセプチンバイオシミラーのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ハーセプチンバイオシミラーの日本市場規模推移 ・ハーセプチンバイオシミラーの中国市場規模推移 ・ハーセプチンバイオシミラーの韓国市場規模推移 ・ハーセプチンバイオシミラーのインド市場規模推移 ・ハーセプチンバイオシミラーの東南アジア市場規模推移 ・ハーセプチンバイオシミラーの南米市場分析（ブラジル、アルゼンチン等） ・ハーセプチンバイオシミラーの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ハーセプチンバイオシミラーの種類別分析/販売量、売上、市場シェア（乳癌、大腸癌、白血病、リンパ腫、その他） ・ハーセプチンバイオシミラーの用途別分析/市場規模（病院及び診療所、腫瘍センター、その他） ・ハーセプチンバイオシミラーの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ハーセプチンバイオシミラーの販売チャネル・代理店・貿易業者・ディーラー分析 |
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein.
Scope of the Report:
The worldwide market for Herceptin Biosimilar is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Herceptin Biosimilar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Amgen
AryoGen Biopharma
Biocon
Celltrion
Gedeon Richter
Genor Biopharma
Mabion
Mylan
Roche
The Instituto Vital Brazil
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Other
Market Segment by Applications, can be divided into
Hospital & Clinics
Oncology Centers
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Herceptin Biosimilar product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Herceptin Biosimilar, with price, sales, revenue and global market share of Herceptin Biosimilar in 2017 and 2018.
Chapter 3, the Herceptin Biosimilar competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Herceptin Biosimilar breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Herceptin Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Herceptin Biosimilar sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Herceptin Biosimilar Introduction
1.2 Market Analysis by Type
1.2.1 Breast Cancer
1.2.2 Colorectal Cancer
1.2.3 Leukemia
1.2.4 Lymphoma
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Hospital & Clinics
1.3.2 Oncology Centers
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Herceptin Biosimilar Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 AryoGen Biopharma
2.2.1 Business Overview
2.2.2 Herceptin Biosimilar Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Biocon
2.3.1 Business Overview
2.3.2 Herceptin Biosimilar Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocon Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Celltrion
2.4.1 Business Overview
2.4.2 Herceptin Biosimilar Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celltrion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Gedeon Richter
2.5.1 Business Overview
2.5.2 Herceptin Biosimilar Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Gedeon Richter Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Genor Biopharma
2.6.1 Business Overview
2.6.2 Herceptin Biosimilar Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Genor Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Mabion
2.7.1 Business Overview
2.7.2 Herceptin Biosimilar Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Mabion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Mylan
2.8.1 Business Overview
2.8.2 Herceptin Biosimilar Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mylan Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Roche
2.9.1 Business Overview
2.9.2 Herceptin Biosimilar Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Roche Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 The Instituto Vital Brazil
2.10.1 Business Overview
2.10.2 Herceptin Biosimilar Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Herceptin Biosimilar Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Herceptin Biosimilar Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Herceptin Biosimilar Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Herceptin Biosimilar Manufacturer Market Share in 2018
3.3.2 Top 6 Herceptin Biosimilar Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Herceptin Biosimilar Market Analysis by Regions
4.1 Global Herceptin Biosimilar Sales, Revenue and Market Share by Regions
4.1.1 Global Herceptin Biosimilar Sales and Market Share by Regions (2014-2019)
4.1.2 Global Herceptin Biosimilar Revenue and Market Share by Regions (2014-2019)
4.2 North America Herceptin Biosimilar Sales and Growth Rate (2014-2019)
4.3 Europe Herceptin Biosimilar Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Herceptin Biosimilar Sales and Growth Rate (2014-2019)
4.5 South America Herceptin Biosimilar Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)
5 North America Herceptin Biosimilar by Country
5.1 North America Herceptin Biosimilar Sales, Revenue and Market Share by Country
5.1.1 North America Herceptin Biosimilar Sales and Market Share by Country (2014-2019)
5.1.2 North America Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)
5.2 United States Herceptin Biosimilar Sales and Growth Rate (2014-2019)
5.3 Canada Herceptin Biosimilar Sales and Growth Rate (2014-2019)
5.4 Mexico Herceptin Biosimilar Sales and Growth Rate (2014-2019)
6 Europe Herceptin Biosimilar by Country
6.1 Europe Herceptin Biosimilar Sales, Revenue and Market Share by Country
6.1.1 Europe Herceptin Biosimilar Sales and Market Share by Country (2014-2019)
6.1.2 Europe Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)
6.2 Germany Herceptin Biosimilar Sales and Growth Rate (2014-2019)
6.3 UK Herceptin Biosimilar Sales and Growth Rate (2014-2019)
6.4 France Herceptin Biosimilar Sales and Growth Rate (2014-2019)
6.5 Russia Herceptin Biosimilar Sales and Growth Rate (2014-2019)
6.6 Italy Herceptin Biosimilar Sales and Growth Rate (2014-2019)
7 Asia-Pacific Herceptin Biosimilar by Country
7.1 Asia-Pacific Herceptin Biosimilar Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Herceptin Biosimilar Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)
7.2 China Herceptin Biosimilar Sales and Growth Rate (2014-2019)
7.3 Japan Herceptin Biosimilar Sales and Growth Rate (2014-2019)
7.4 Korea Herceptin Biosimilar Sales and Growth Rate (2014-2019)
7.5 India Herceptin Biosimilar Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Herceptin Biosimilar Sales and Growth Rate (2014-2019)
8 South America Herceptin Biosimilar by Country
8.1 South America Herceptin Biosimilar Sales, Revenue and Market Share by Country
8.1.1 South America Herceptin Biosimilar Sales and Market Share by Country (2014-2019)
8.1.2 South America Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)
8.2 Brazil Herceptin Biosimilar Sales and Growth Rate (2014-2019)
8.3 Argentina Herceptin Biosimilar Sales and Growth Rate (2014-2019)
8.4 Colombia Herceptin Biosimilar Sales and Growth Rate (2014-2019)
9 Middle East and Africa Herceptin Biosimilar by Countries
9.1 Middle East and Africa Herceptin Biosimilar Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Herceptin Biosimilar Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Herceptin Biosimilar Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Herceptin Biosimilar Sales and Growth Rate (2014-2019)
9.3 Turkey Herceptin Biosimilar Sales and Growth Rate (2014-2019)
9.4 Egypt Herceptin Biosimilar Sales and Growth Rate (2014-2019)
9.5 Nigeria Herceptin Biosimilar Sales and Growth Rate (2014-2019)
9.6 South Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)
10 Global Herceptin Biosimilar Market Segment by Type
10.1 Global Herceptin Biosimilar Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Herceptin Biosimilar Sales and Market Share by Type (2014-2019)
10.1.2 Global Herceptin Biosimilar Revenue and Market Share by Type (2014-2019)
10.2 Breast Cancer Sales Growth and Price
10.2.1 Global Breast Cancer Sales Growth (2014-2019)
10.2.2 Global Breast Cancer Price (2014-2019)
10.3 Colorectal Cancer Sales Growth and Price
10.3.1 Global Colorectal Cancer Sales Growth (2014-2019)
10.3.2 Global Colorectal Cancer Price (2014-2019)
10.4 Leukemia Sales Growth and Price
10.4.1 Global Leukemia Sales Growth (2014-2019)
10.4.2 Global Leukemia Price (2014-2019)
10.5 Lymphoma Sales Growth and Price
10.5.1 Global Lymphoma Sales Growth (2014-2019)
10.5.2 Global Lymphoma Price (2014-2019)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2014-2019)
10.6.2 Global Other Price (2014-2019)
11 Global Herceptin Biosimilar Market Segment by Application
11.1 Global Herceptin Biosimilar Sales Market Share by Application (2014-2019)
11.2 Hospital & Clinics Sales Growth (2014-2019)
11.3 Oncology Centers Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Herceptin Biosimilar Market Forecast (2019-2024)
12.1 Global Herceptin Biosimilar Sales, Revenue and Growth Rate (2019-2024)
12.2 Herceptin Biosimilar Market Forecast by Regions (2019-2024)
12.2.1 North America Herceptin Biosimilar Market Forecast (2019-2024)
12.2.2 Europe Herceptin Biosimilar Market Forecast (2019-2024)
12.2.3 Asia-Pacific Herceptin Biosimilar Market Forecast (2019-2024)
12.2.4 South America Herceptin Biosimilar Market Forecast (2019-2024)
12.2.5 Middle East and Africa Herceptin Biosimilar Market Forecast (2019-2024)
12.3 Herceptin Biosimilar Market Forecast by Type (2019-2024)
12.3.1 Global Herceptin Biosimilar Sales Forecast by Type (2019-2024)
12.3.2 Global Herceptin Biosimilar Market Share Forecast by Type (2019-2024)
12.4 Herceptin Biosimilar Market Forecast by Application (2019-2024)
12.4.1 Global Herceptin Biosimilar Sales Forecast by Application (2019-2024)
12.4.2 Global Herceptin Biosimilar Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Herceptin Biosimilar Picture
Table Product Specifications of Herceptin Biosimilar
Figure Global Sales Market Share of Herceptin Biosimilar by Types in 2018
Table Herceptin Biosimilar Types for Major Manufacturers
Figure Breast Cancer Picture
Figure Colorectal Cancer Picture
Figure Leukemia Picture
Figure Lymphoma Picture
Figure Other Picture
Figure Herceptin Biosimilar Sales Market Share by Applications in 2018
Figure Hospital & Clinics Picture
Figure Oncology Centers Picture
Figure Other Picture
Figure United States Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure France Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure UK Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure China Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure India Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Herceptin Biosimilar Revenue (Value) and Growth Rate (2014-2024)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Herceptin Biosimilar Type and Applications
Table Amgen Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AryoGen Biopharma Basic Information, Manufacturing Base and Competitors
Table AryoGen Biopharma Herceptin Biosimilar Type and Applications
Table AryoGen Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Herceptin Biosimilar Type and Applications
Table Biocon Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Celltrion Basic Information, Manufacturing Base and Competitors
Table Celltrion Herceptin Biosimilar Type and Applications
Table Celltrion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table Gedeon Richter Herceptin Biosimilar Type and Applications
Table Gedeon Richter Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Genor Biopharma Basic Information, Manufacturing Base and Competitors
Table Genor Biopharma Herceptin Biosimilar Type and Applications
Table Genor Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Mabion Basic Information, Manufacturing Base and Competitors
Table Mabion Herceptin Biosimilar Type and Applications
Table Mabion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Herceptin Biosimilar Type and Applications
Table Mylan Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Herceptin Biosimilar Type and Applications
Table Roche Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table The Instituto Vital Brazil Basic Information, Manufacturing Base and Competitors
Table The Instituto Vital Brazil Herceptin Biosimilar Type and Applications
Table The Instituto Vital Brazil Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Herceptin Biosimilar Sales by Manufacturer (2017-2018)
Figure Global Herceptin Biosimilar Sales Market Share by Manufacturer in 2017
Figure Global Herceptin Biosimilar Sales Market Share by Manufacturer in 2018
Table Global Herceptin Biosimilar Revenue by Manufacturer (2017-2018)
Figure Global Herceptin Biosimilar Revenue Market Share by Manufacturer in 2017
Figure Global Herceptin Biosimilar Revenue Market Share by Manufacturer in 2018
Figure Top 3 Herceptin Biosimilar Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Herceptin Biosimilar Manufacturer (Revenue) Market Share in 2018
Figure Global Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Global Herceptin Biosimilar Revenue and Growth Rate (2014-2019)
Table Global Herceptin Biosimilar Sales by Regions (2014-2019)
Table Global Herceptin Biosimilar Sales Market Share by Regions (2014-2019)
Table Global Herceptin Biosimilar Revenue by Regions (2014-2019)
Figure Global Herceptin Biosimilar Revenue Market Share by Regions (2014-2019)
Figure Global Herceptin Biosimilar Revenue Market Share by Regions in 2018
Figure North America Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Europe Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure South America Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure North America Herceptin Biosimilar Revenue and Growth Rate (2014-2019)
Table North America Herceptin Biosimilar Sales by Countries (2014-2019)
Table North America Herceptin Biosimilar Sales Market Share by Countries (2014-2019)
Figure North America Herceptin Biosimilar Sales Market Share by Countries (2014-2019)
Figure North America Herceptin Biosimilar Sales Market Share by Countries in 2018
Table North America Herceptin Biosimilar Revenue by Countries (2014-2019)
Table North America Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)
Figure North America Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)
Figure North America Herceptin Biosimilar Revenue Market Share by Countries in 2018
Figure United States Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Canada Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Mexico Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Europe Herceptin Biosimilar Revenue and Growth Rate (2014-2019)
Table Europe Herceptin Biosimilar Sales by Countries (2014-2019)
Table Europe Herceptin Biosimilar Sales Market Share by Countries (2014-2019)
Table Europe Herceptin Biosimilar Revenue by Countries (2014-2019)
Figure Europe Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)
Figure Europe Herceptin Biosimilar Revenue Market Share by Countries in 2018
Figure Germany Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure UK Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure France Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Russia Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Italy Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Herceptin Biosimilar Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Herceptin Biosimilar Sales by Countries (2014-2019)
Table Asia-Pacific Herceptin Biosimilar Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Herceptin Biosimilar Sales Market Share by Countries 2018
Table Asia-Pacific Herceptin Biosimilar Revenue by Countries (2014-2019)
Figure Asia-Pacific Herceptin Biosimilar Revenue Market Share by Countries 2018
Figure China Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Japan Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Korea Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure India Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Southeast Asia Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure South America Herceptin Biosimilar Revenue and Growth Rate (2014-2019)
Table South America Herceptin Biosimilar Sales by Countries (2014-2019)
Table South America Herceptin Biosimilar Sales Market Share by Countries (2014-2019)
Figure South America Herceptin Biosimilar Sales Market Share by Countries in 2018
Table South America Herceptin Biosimilar Revenue by Countries (2014-2019)
Table South America Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)
Figure South America Herceptin Biosimilar Revenue Market Share by Countries in 2018
Figure Brazil Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Argentina Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Colombia Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Herceptin Biosimilar Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Herceptin Biosimilar Sales by Countries (2014-2019)
Table Middle East and Africa Herceptin Biosimilar Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Herceptin Biosimilar Sales Market Share by Countries in 2018
Table Middle East and Africa Herceptin Biosimilar Revenue by Countries (2014-2019)
Table Middle East and Africa Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Herceptin Biosimilar Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Herceptin Biosimilar Revenue Market Share by Countries in 2018
Figure Saudi Arabia Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure UAE Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Egypt Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure Nigeria Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Figure South Africa Herceptin Biosimilar Sales and Growth Rate (2014-2019)
Table Global Herceptin Biosimilar Sales by Type (2014-2019)
Table Global Herceptin Biosimilar Sales Share by Type (2014-2019)
Table Global Herceptin Biosimilar Revenue by Type (2014-2019)
Table Global Herceptin Biosimilar Revenue Share by Type (2014-2019)
Figure Global Breast Cancer Sales Growth (2014-2019)
Figure Global Breast Cancer Price (2014-2019)
Figure Global Colorectal Cancer Sales Growth (2014-2019)
Figure Global Colorectal Cancer Price (2014-2019)
Figure Global Leukemia Sales Growth (2014-2019)
Figure Global Leukemia Price (2014-2019)
Figure Global Lymphoma Sales Growth (2014-2019)
Figure Global Lymphoma Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Herceptin Biosimilar Sales by Application (2014-2019)
Table Global Herceptin Biosimilar Sales Share by Application (2014-2019)
Figure Global Oncology Centers Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Herceptin Biosimilar Sales, Revenue and Growth Rate (2019-2024)
Table Global Herceptin Biosimilar Sales Forecast by Regions (2019-2024)
Table Global Herceptin Biosimilar Market Share Forecast by Regions (2019-2024)
Figure North America Sales Herceptin Biosimilar Market Forecast (2019-2024)
Figure Europe Sales Herceptin Biosimilar Market Forecast (2019-2024)
Figure Asia-Pacific Sales Herceptin Biosimilar Market Forecast (2019-2024)
Figure South America Sales Herceptin Biosimilar Market Forecast (2019-2024)
Figure Middle East and Africa Sales Herceptin Biosimilar Market Forecast (2019-2024)
Table Global Herceptin Biosimilar Sales Forecast by Type (2019-2024)
Table Global Herceptin Biosimilar Market Share Forecast by Type (2019-2024)
Table Global Herceptin Biosimilar Sales Forecast by Application (2019-2024)
Table Global Herceptin Biosimilar Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の転移性大腸がんの治療市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…- 世界の転移性結腸直腸がん手術市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- 世界の白血病がん市場：市場規模・現状・予測 Leukemia is a group ofcancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. High incidence rate of blood cancers and rise in incidence of leukaemia across the globe will drive the leukemia market. In 2018, the global Leukemia Cancer market size was x…
- 乳がんPARP阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global PARP Inhibitors for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially i…
- 乳がんCDK4 / 6阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global CDK4/6 Inhibitors for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…